Acute shortage of Panadol tablets in Lahore
Stay tuned with 24 News HD Android App
According to the Drug Regulatory Authority of Pakistan (DRAP), the relevant brand has stopped its pharmaceutical business in Pakistan.
The makers claimed issues with the cost-effective nature of the drug to be the main reason behind its halted production. The company was also urging the local authorities to increase the drug price but their demands were not catered to.
The companies produced self-imposed shortages in order to raise the price of Panadol, claimed sources.
On the other hand, patients are raising eyebrows as Panadol is one of the most in-demand drugs in Pakistan due to the increasing cases of dengue.
Reporter: Azmat Awan